Approved Prospectus

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG OR JAPAN OR SUCH OTHER JURISDICTIONS WHERE THE OFFERING AND SALE OF THE NEW SHARES AND THE SUBSCRIPTION RIGHTS IS RESTRICTED BY LAW.

The Financial Supervisory Authority of Norway has approved the following prospectus:

Prospectus for rights offering and subsequent listing of 100,000,000 new shares (the "New Shares") each with a par value of NOK 0.20 at a subscription price of NOK 0.50 per New Share (the “Prospectus”)

DiaGenic ASA

The information contained in the Prospectus relates to a rights offering (the "Rights Offering") and subsequent listing of 100,000,000 New Shares each with a par value of NOK 0.20 at a subscription price of NOK 0.50 per New Share (the "Subscription Price"), with subscription rights ("Subscription Rights") for existing shareholders (the "Existing Shareholders") of DiaGenic ASA (the "Company") as of the end of 25 February 2014 as appearing in the Norwegian Central Securities Depository ("VPS") on 28 February 2014 (the “Record Date”). The Rights Offering is fully underwritten by an underwriting syndicate.

Each Eligible Shareholder will be granted 12.25509 Subscription Rights for each Share registered as held by such Eligible Shareholder as of the Record Date rounded down to the nearest whole Subscription Right. Each Subscription Right will, subject to applicable securities laws, give the right to subscribe for and be allocated one New Share.

Subscription Period for the Rights Offering:

The subscription period for the Rights Issue commences on 17 March 2014 and expires at 17:30 hours, Central European Time (“CET”), on 31 March 2014 (the “Subscription Period”). The Subscription Rights will be tradable on Oslo Børs during the Subscription Period under the ticker symbol “DIAG S”.

Important notice: Subscription Rights that are not used to subscribe for New Shares before the end of the Subscription Period will have no value and will lapse without compensation to the holder.

Manager for the Rights Issue is Arctic Securities ASA

The information in this notice is not complete. For further information see Prospectus dated 14 March 2014 which is available online at www.diagenic.com and www.arcticsec.no. The Prospectus can also be obtained physically from the Manager and will be available to the public from 17 March 2014:

The Manager:

Arctic Securities ASA

P.O. Box 1833 Vika

Haakon VII's gt. 5

0123 Oslo

Norway

www.arcticsec.no